Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 122  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page


 
Table of Contents 
CORRESPONDENCE
Year : 2012  |  Volume : 57  |  Issue : 6  |  Page : 499
Authors' Reply


Department of Dermatology, Sri Ramachandra University, Porur, Chennai, Tamil Nadu, India

Date of Web Publication1-Nov-2012

Correspondence Address:
Thirthar Palanivelu Vetrichevvel
Department of Dermatology, Sri Ramachandra University, Porur, Chennai, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions



How to cite this article:
Vetrichevvel TP, Sudha R, Shobana S, Anandan S. Authors' Reply. Indian J Dermatol 2012;57:499

How to cite this URL:
Vetrichevvel TP, Sudha R, Shobana S, Anandan S. Authors' Reply. Indian J Dermatol [serial online] 2012 [cited 2020 May 30];57:499. Available from: http://www.e-ijd.org/text.asp?2012/57/6/499/103076


Sir,

We thank the authors for their interest in our article, "Zosteriform fixed drug eruption to Levofloxacin". [1] Our patient had presented with fixed drug eruption (FDE) associated with multiple fluid filled lesions on the lateral trunk, a clinical picture reminisce of herpes zoster. However, we have expressed our limitations on a dermatomal cause as "inexplicable" and highlighted this unique presentation of FDE due to Levofloxacin.

In our attempt to identify the cause of this unique presentation, we had presented to the readers, an exhaustive list of possible causes including viscero-cutaneous reflex zones and negated them based on history and examination. We would like to underline the fact that, in our discussion on the possibility of linear and disseminated drug eruption, we had also mentioned the concept of heterozygosity and homozygosity that forms the genetic basis that could explain the clinical appearance of these lesions and have duly referenced Happle et al.'s article on co-existing linear and disseminated drug eruption. However, we acknowledge the author's contribution in emphasizing and explaining the paradigm.

 
   References Top

1.Vetrichevvel TP, Sudha R, Shobana S, Anandan S. Zosteriform fixed drug eruption to levofloxacin. Indian J Dermatol 2012;57:327-8.  Back to cited text no. 1
[PUBMED]  Medknow Journal  




 

Top
Print this article  Email this article
 
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (313 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1394    
    Printed41    
    Emailed0    
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal